Reference number : GC-2017-Q2-04360, amendment number : , agreement type : G, recipient legal name : Ma, Hongshen (The University of British Columbia), recipient country : CA, recipient province : nan, recipient city : British Columbia|Colombie-Britannique, recipient postal code : nan, program name english : Collaborative Research and Development Grants - Project, program name french : Subventions de recherche et développement coopérative - projet, program purpose english : Point-of-care tests are medical diagnostic tests performed outside of clinical laboratories and in close proximity of patients receiving care, such as at homes, doctor's offices, and emergency departments in hospitals. The ability to perform diagnostic tests without requiring sophisticated laboratory equipment and infrastructure is important for many health conditions including cancer, heart disease, and viral infections. This proposal aims to develop a new technology to perform point-of-care diagnostic tests utilizing methods developed for manufacturing silicon microchips, which can be adapted to enable precise control over the flow of extremely small volumes of liquid. This capability enables sophisticated biochemical analyses to be performed in portable, low-cost, and automated system, which can be utilized by patients and care providers at the point of care., program purpose french : Point-of-care tests are medical diagnostic tests performed outside of clinical laboratories and in close proximity of patients receiving care, such as at homes, doctor's offices, and emergency departments in hospitals. The ability to perform diagnostic tests without requiring sophisticated laboratory equipment and infrastructure is important for many health conditions including cancer, heart disease, and viral infections. This proposal aims to develop a new technology to perform point-of-care diagnostic tests utilizing methods developed for manufacturing silicon microchips, which can be adapted to enable precise control over the flow of extremely small volumes of liquid. This capability enables sophisticated biochemical analyses to be performed in portable, low-cost, and automated system, which can be utilized by patients and care providers at the point of care., agreement title english : Microfluidic point-of-care immunoassay, agreement title french : Microfluidic point-of-care immunoassay, agreement number : CRDPJ, agreement value : 467450.0, agreement start date : 2017-09-20, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2020-2021)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2020-2021)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada